The FDA’s ANDA080301 filing for Marshall Pharma lists a single oral product: Prednisone 5 mg tablets (product number 001). The product is classified as a tablet dosage form, contains the active ingredient prednisone at a strength of 5 mg, and is marked as a discontinued marketing status. No reference drug or reference standard is indicated.
Sponsor: Marshall Pharma.
Regulatory UpdatesSep 8, 2026•1 min read
Marshall Pharma Prednisone Tablet (5 mg) ANDA080301 Discontinued
FDA records indicate Marshall Pharma's oral prednisone 5 mg tablet (product 001) under application ANDA080301 is listed as discontinued.
Compiled by the PharmaCountry team · Source: FDA.gov
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating